Advertisement

Pharmacy

GlaxoSmithKline is recalling prescription-only versions of its heartburn medicine Zantac globally after the U.S. Food and Drug Administration found "unacceptable" levels of a potential carcinogen in the drug, according to Channel News Asia.

Advertisement

Jim Greenwood, the CEO of the drug industry lobby Biotech Innovation Organization, will step down at the end of 2020, according to Politico.

Charlotte, N.C.-based Premier's ProvideGx program is partnering with Amphastar Pharmaceuticals to supply hospitals with seven drugs in critical shortage.

Michigan's Medicaid program might stop using its contracted, third party pharmacy benefit managers to handle prescription drug claims and price negotiations. Instead the state would manage drug coverage itself, according to a Sept. 30 proposed policy draft.

Advertisement